Coronavirus (COVID-19) Support Resource Center
Is your Toyota or Lexus putting you at risk?

Is your Toyota or Lexus putting you at risk?

Keller Rohrback is investigating reports that up to 1.8 million Toyota and Lexus sedans, crossovers and SUVs equipped with Denso-brand fuel pumps suffer from serious problems that could cause vehicles to stall at speed, fail to accelerate, or run poorly. If you or someone you know owns or leases one of the vehicles listed below, please contact Keller Rohrback’s automotive litigation team at (800) 776-6044 to discuss your legal rights.

Is your pension at risk in the hands of American General Insurance Company (AIG)?

Is your pension at risk in the hands of American General Insurance Company (AIG)?

Keller Rohrback is investigating whether Avery Dennison and Rollins, Inc. violated federal law by turning over their employees’ and retirees’ pensions to American General Insurance Company, a subsidiary of AIG–a notoriously risky insurer. If you were or are employed by Avery Dennison, Rollins, Inc. or another company that turned its pensions over to American General Insurance Company and are concerned that your pension may be at risk, please contact us at (800) 776-6044.

Is Your Jeep or Fiat SUV Stalling from Consuming Too Much Oil?

Is Your Jeep or Fiat SUV Stalling from Consuming Too Much Oil?

Keller Rohrback is investigating reports that certain Jeep and Fiat crossovers and SUVs equipped with 2.4-Liter “Tigershark” engines are consuming too much oil, allegedly causing the vehicles to stall, and often at high speeds. If you or someone you know owns or leases one of the vehicles listed below, please contact Keller Rohrback’s automotive litigation team at cars@kellerrohrback.com or (800) 776-6044 to discuss your legal rights.

Keller Rohrback Announces Tenth Circuit Victory in EpiPens Case Against Mylan and Pfizer

Keller Rohrback Announces Tenth Circuit Victory in EpiPens Case Against Mylan and Pfizer

Today, the Tenth Circuit Court of Appeals rejected Defendants’ bid to appeal the district court’s class certification order for a nationwide RICO class in In re EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation, the multidistrict litigation against Mylan and Pfizer that seeks to hold Defendants accountable for forcing consumers to pay inflated prices for EpiPens. Today’s order allows the class action to move forward toward trial, which is scheduled for April 2021.

Keller Rohrback Named Law360 Legal Lion

Keller Rohrback Named Law360 Legal Lion

Last week, a Washington federal judge granted the City of Seattle’s motion to dismiss the ERISA Industry Committee v City of Seattle case, which challenged the City’s landmark law requiring large hotels to provide access to adequate health care for their employees and the employees’ families. The motion was granted without leave to amend. Our work on this case led to the firm being named one of Law360’s Legal Lions.

Website Design by 3Circle Media